Phase II evaluation of 4'epi-doxorubicin in patients with metastatic colorectal carcinoma.

Ferrazzi, E; Pappagallo, G L; Nicoletto, O; Fornasiero, A; Refatti, F; Cartei, G; Vinante, O; Fiorentino, M V

Ferrazzi, E; Pappagallo, G L; Nicoletto, O; Fornasiero, A; Refatti, F; Cartei, G; Vinante, O; Fiorentino, M V.

Tumori ; 70(3): 297-300, 1984 Jun 30.

Article in En | MEDLINE | ID: mdl-6588671

Subject(s)

Antibiotics, Antineoplastic/therapeutic use; Colonic Neoplasms/drug therapy; Doxorubicin/therapeutic use; Rectal Neoplasms/drug therapy; Adult; Aged; Antibiotics, Antineoplastic/adverse effects; Doxorubicin/adverse effects; Drug Evaluation; Epirubicin; Female; Humans; Male; Middle Aged; Neoplasm Metastasis

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Rectal Neoplasms / Doxorubicin / Colonic Neoplasms / Antibiotics, Antineoplastic Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Tumori Year: 1984 Document type: Article Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links